Matches in Nanopublications for { ?s ?p "[Based on published data that show a survival advantage for patients who achieved any cytogenetic response, and high rate of cytogenetic response which we observed in our study we believe that IFN plus AraC regimen could be a front-line therapy for CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP294960.RAjYY24ldNcy5TJARJE93h00V6JyFyoouxgedR1MnQ5Bg130_assertion description "[Based on published data that show a survival advantage for patients who achieved any cytogenetic response, and high rate of cytogenetic response which we observed in our study we believe that IFN plus AraC regimen could be a front-line therapy for CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294960.RAjYY24ldNcy5TJARJE93h00V6JyFyoouxgedR1MnQ5Bg130_provenance.
- NP294961.RA5ERtVQe3m8kaGo1B5vaZP9rrq0-bbsMUGKJGjGRDWak130_assertion description "[Based on published data that show a survival advantage for patients who achieved any cytogenetic response, and high rate of cytogenetic response which we observed in our study we believe that IFN plus AraC regimen could be a front-line therapy for CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294961.RA5ERtVQe3m8kaGo1B5vaZP9rrq0-bbsMUGKJGjGRDWak130_provenance.